| 1 |
Christensen K, Doblhammer G, Rau R, et al. Ageing populations: the challenges ahead[J]. Lancet, 2009, 374 (9696): 1196-1208.
|
| 2 |
de Magalhaes JP. An overview of contemporary theories of ageing[J]. Nat Cell Biol, 2025, 27 (7): 1074-1082.
|
| 3 |
O'Toole PW, Jeffery IB. Gut microbiota and aging[J]. Science, 2015, 350 (6265): 1214-1215.
|
| 4 |
朱金伟，陆件，宁文娜，等.基于肠道生物标志物探讨三种营养策略对重度胃肠损伤患者的价值[J/OL].中华危重症医学杂志（电子版），2024，17（2）：111-117.
|
| 5 |
Van Hul M, Cani PD, Petitfils C, et al. What defines a healthy gut microbiome?[J]. Gut, 2024, 73 (11): 1893-1908.
|
| 6 |
李姝敏，张勤，吴月，等.老年人大便性状与肠道菌群的相关性分析[J/OL].中华危重症医学杂志（电子版），2018，11（4）：217-222.
|
| 7 |
Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome[J]. Nature, 2011, 473 (7346): 174-180.
|
| 8 |
Costea PI, Hildebrand F, Arumugam M, et al. Enterotypes in the landscape of gut microbial community composition[J]. Nat Microbiol, 2018, 3 (1): 8-16.
|
| 9 |
Frost F, Lerch MM. Gut microbial pathways for bile acid metabolism[J]. Hepatobiliary Surg Nutr, 2021, 10 (3): 379-381.
|
| 10 |
Funabashi M, Grove TL, Wang M, et al. A metabolic pathway for bile acid dehydroxylation by the gut microbiome[J]. Nature, 2020, 582 (7813): 566-570.
|
| 11 |
Kim CH. Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity[J]. Cell Mol Immunol, 2023, 20 (4): 341-350.
|
| 12 |
Cheng M, Ning K. Stereotypes about enterotype: the old and new ideas[J]. Genomics Proteomics Bioinformatics, 2019, 17 (1): 4-12.
|
| 13 |
Wu GD, Chen J, Hoffmann C, et al. Linking long-term dietary patterns with gut microbial enterotypes[J]. Science, 2011, 334 (6052): 105-108.
|
| 14 |
Walker AW, Ince J, Duncan SH, et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota[J]. ISME J, 2010, 5 (2): 220-230.
|
| 15 |
Claesson MJ, Jeffery IB, Conde S, et al. Gut microbiota composition correlates with diet and health in the elderly[J]. Nature, 2012, 488 (7410): 178-184.
|
| 16 |
Palmer C, Bik EM, DiGiulio DB, et al. Development of the human infant intestinal microbiota[J]. PLoS Biol, 2007, 5 (7): e177.
|
| 17 |
Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora[J]. Science, 2005, 308 (5728): 1635-1638.
|
| 18 |
Costello EK, Lauber CL, Hamady M, et al. Bacterial community variation in human body habitats across space and time[J]. Science, 2009, 326 (5960): 1694-1697.
|
| 19 |
Claesson MJ, Cusack S, O'Sullivan O, et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly[J]. Proc Natl Acad Sci U S A, 2010, 108 (Suppl 1): 4586-4591.
|
| 20 |
Abahussin HM, Alotaibi MS, Alhazzaa OA, et al. Exploring the intricate link between gut microbiota dysbiosis and the aging process: implications for age-related diseases[J]. Gut Pathog, 2025, 18 (1): 3.
|
| 21 |
Hicks LA, Bartoces MG, Roberts RM, et al. US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011[J]. Clin Infect Dis, 2015, 60 (9): 1308-1316.
|
| 22 |
Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation[J]. Proc Natl Acad Sci U S A, 2010, 108 (Suppl 1): 4554-4561.
|
| 23 |
Pérez-Cobas AE, Gosalbes MJ, Friedrichs A, et al. Gut microbiota disturbance during antibiotic therapy: a multi-omic approach[J]. Gut, 2012, 62 (11): 1591-1601.
|
| 24 |
Pallav K, Dowd SE, Villafuerte J, et al. Effects of polysaccharopeptide from Trametes versicolor and amoxicillin on the gut microbiome of healthy volunteers: a randomized clinical trial[J]. Gut Microbes, 2014, 5 (4): 458-467.
|
| 25 |
Hernández E, Bargiela R, Diez MS, et al. Functional consequences of microbial shifts in the human gastrointestinal tract linked to antibiotic treatment and obesity[J]. Gut Microbes, 2013, 4 (4): 306-315.
|
| 26 |
Raymond F, Ouameur AA, Déraspe M, et al. The initial state of the human gut microbiome determines its reshaping by antibiotics[J]. ISME J, 2015, 10 (3): 707-720.
|
| 27 |
Baldanzi G, Larsson A, Sayols-Baixeras S, et al. Antibiotic use and gut microbiome composition links from individual-level prescription data of 14 979 individuals[J]. Nat Med, 2026, 32 (4): 1351-1361.
|
| 28 |
Lynch SV, Pedersen O. The human intestinal microbiome in health and disease[J]. N Engl J Med, 2016, 375 (24): 2369-2379.
|
| 29 |
韩宾，叶航羊，黄登，等.肠系膜静脉血栓形成发病机制的研究进展[J].中华消化外科杂志，2026，25（6）：829-836.
|
| 30 |
Kim BS, Choi CW, Shin H, et al. Comparison of the gut microbiota of centenarians in longevity villages of South Korea with those of other age groups[J]. J Microbiol Biotechnol, 2019, 29 (3): 429-440.
|
| 31 |
Ragonnaud E, Biragyn A. Gut microbiota as the key controllers of "healthy" aging of elderly people[J]. Immun Ageing, 2021, 18 (1): 2.
|
| 32 |
Aznou A, Drenth JPH, Nieuwdorp M, et al. Exploring the role of the gut microbiome across the lifespan: implications for aging and metabolic disorders[J]. J Endocr Soc, 2025, 9 (10): bvaf130.
|
| 33 |
Odamaki T, Kato K, Sugahara H, et al. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study[J]. BMC Microbiol, 2016, 16: 90.
|
| 34 |
Kong F, Hua Y, Zeng B, et al. Gut microbiota signatures of longevity[J]. Curr Biol, 2016, 26 (18): R832-R833.
|
| 35 |
Jeffery IB, Lynch DB, O'Toole PW. Composition and temporal stability of the gut microbiota in older persons[J]. ISME J, 2015, 10 (1): 170-182.
|
| 36 |
Ticinesi A, Milani C, Lauretani F, et al. Gut microbiota composition is associated with polypharmacy in elderly hospitalized patients[J]. Sci Rep, 2017, 7 (1): 11102.
|